Ingrid Øra
21 – 30 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
NTRK Alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets
(
- Contribution to journal › Letter
-
Mark
Cognitive Fatigue and Processing Speed in Children Treated for Brain Tumours
(
- Contribution to journal › Article
-
Mark
Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients
(
- Contribution to journal › Article
-
Mark
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)
(
- Contribution to journal › Article
-
Mark
Characterization of Cardiac, Vascular, and Metabolic Changes in Young Childhood Cancer Survivors
(
- Contribution to journal › Article
-
Mark
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
(
- Contribution to journal › Article
-
Mark
The pediatric precision oncology INFORM registry : clinical outcome and benefit for patients with very high-evidence targets
(
- Contribution to journal › Article
- 2020
-
Mark
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe : A report from the Innovative Therapies for Children with Cancer (ITCC) consortium
(
- Contribution to journal › Article
-
Mark
A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
2020) In Blood(
- Contribution to journal › Article
-
Mark
Cognitive fatigue in relation to depressive symptoms after treatment for childhood cancer
(
- Contribution to journal › Article